VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NVST
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NVSTEnvista Holdings Corp
$27.13$4.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

NVST logoEnvista Holdings Corp(NVST)Earnings, Financials & Key Ratios

NVST•NYSE
$27.13
96.9× P/E·Price updated Jul 7, 2026
SectorHealthcareIndustryMedical EquipmentSub-IndustryMedical Devices and Procedure Tools
AboutEnvista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.Show more
  • Revenue$2.72B+8.3%
  • EBITDA$342M+137.3%
  • Net Income$47M+104.2%
  • EPS (Diluted)0.28+104.3%
  • Gross Margin55.02%-0.7%
  • EBITDA Margin12.56%+134.5%
  • Operating Margin8.3%+120.1%
  • Net Margin1.73%+103.9%
  • ROE1.56%+104.9%

NVST Price & Volume

Envista Holdings Corp (NVST) stock price & volume — 10-year historical chart

Loading chart...

Volatile Revenue Growth Masks Structural Profitability Challenges

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Mixed
Profitability:Strained
Financial:Mixed
Cash Flow:Mixed
Primary Risk:Margin compression and cyclicality

Key Thesis Takeaways

  • Envista Holdings faces a challenging fundamental outlook characterized by inconsistent revenue growth, which oscillated from a 4.8% contraction in 2024Q3 to a 15.0% expansion by 2025Q4.
  • The company's reliance on $2.4 billion in goodwill and a shift to a $401.7 million retained earnings deficit suggests significant long-term value destruction.
  • Investors should remain cautious as the firm struggles to convert gross margins of 55.3% into sustainable operating profitability, further complicated by aggressive capital allocation despite negative free cash flow of $15.8 million in 2026Q1.

Verdict Logic

the company's inability to maintain consistent profitability is highlighted by a 2026Q1 net margin of 5.5% and a concerning shift to a $401.7 million retained earnings deficit.

NVST Growth Metrics

Envista Holdings Corp (NVST) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years7.11%
3 Years1.91%
TTM12.15%

Profit CAGR

10 Years-
5 Years7.13%
3 Years-42.18%
TTM106.02%

EPS CAGR

10 Years-
5 Years1.49%
3 Years-40.66%
TTM106.27%

Return on Capital

10 Years1.68%
5 Years-0.6%
3 Years-4.92%
Last Year4.85%

NVST Recent Earnings

Envista Holdings Corp (NVST) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$0.36+16.1%
$0.31
Rev
$706M+3.7%
$680M
Q1 2026
Feb 5, 2026
Metric
Actual
Est
EPS
$0.38+18.8%
$0.32
Rev
$751M+10.4%
$680M
Q4 2025
Oct 29, 2025
Metric
Actual
Est
EPS
$0.32+18.5%
$0.27
Rev
$670M-1.5%
$680M
Q3 2025
Jul 31, 2025
Metric
Actual
Est
EPS
$0.26+8.3%
$0.24
Rev
$682M+6.2%
$643M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.36vs $0.31+16.1%
$706Mvs $680M+3.7%
Q1 2026Feb 5, 2026
$0.38vs $0.32+18.8%
$751Mvs $680M+10.4%
Q4 2025Oct 29, 2025
$0.32vs $0.27+18.5%
$670Mvs $680M-1.5%
Q3 2025Jul 31, 2025
$0.26vs $0.24+8.3%
$682Mvs $643M+6.2%
Based on last 12 quarters of dataView full earnings history →

Latest NVST News

Recent stock market news and headlines for Envista Holdings Corp (NVST)

PRNewsWire·19h ago
Envista Schedules Second Quarter 2026 Earnings Call

BREA, Calif., July 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2026 on Wednesday, August 5, 2026.

Zacks Investment Research·Jun 19, 2026
NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?

Envista rises 37.1% in a year as new dental product launches, margin gains, acquisitions and a strong balance sheet fuel growth.

Peers Comparison

Key metrics vs top competitors for Envista Holdings Corp (NVST)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NVST logoNVSTEnvista Holdings CorpCurrent
$27.13$4.42B96.898.32%1.73%1.56%—
XRAY logoXRAYDENTSPLY SIRONA Inc.
$12.19$2.44B-4.06-2.98%-17.06%-41.19%—
ALGN logoALGNAlign Technology, Inc.
$185.22$13.26B32.780.9%10.5%10.7%—
HSIC logoHSICHenry Schein, Inc.
$86.84$9.89B26.564.03%2.95%8.14%—
MMSI logoMMSIMerit Medical Systems, Inc.
$72.14$4.3B33.8711.66%9.03%8.95%—
NVCR logoNVCRNovoCure Limited
$17.72$2.02B-14.528.28%-25.66%-50.82%—

Compare NVST vs Peers

Envista Holdings Corp (NVST) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs XRAY

Most directly comparable listed peer for NVST.

Scale Benchmark

vs DHR

Larger-name benchmark to compare NVST against a more recognizable public peer.

Peer Set

Compare Top 5

vs XRAY, ALGN, HSIC, MMSI

NVST SEC Filings & Documents

Envista Holdings Corp (NVST) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Feb 5, 2026·SEC

Material company update

Oct 29, 2025·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 13, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

Get notified when NVST posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NVST Frequently Asked Questions

Envista Holdings Corp (NVST) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Envista Holdings Corp's revenue?

Envista Holdings Corp (NVST) reported $2.81B in revenue for fiscal year 2025. This represents a 0% decrease from $2.81B in 2017.

How fast is Envista Holdings Corp growing?

Envista Holdings Corp (NVST) grew revenue by 8.3% over the past year. This is steady growth.

Is NVST profitable?

Yes, Envista Holdings Corp (NVST) is profitable, generating $67.7M in net income for fiscal year 2025 (1.7% net margin).

Dividend & Returns
What is NVST's return on equity?

Envista Holdings Corp (NVST) has a return on equity (ROE) of 1.6%. This is below average, suggesting room for improvement.

What is Envista Holdings Corp's free cash flow?

Envista Holdings Corp (NVST) generated $220.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in NVST back in 2017?

Total return calculator · dividends reinvested · 9+ years of data

See returns →